Related Experiment Videos
The splicing factor U1C represses EWS/FLI-mediated transactivation.
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
The Journal of Biological Chemistry
|May 29, 2000
Summary
U1C, a splicing factor, interacts with EWS and EWS/FLI, proteins implicated in Ewing sarcoma. This interaction represses EWS/FLI
Area of Science:
- Molecular Biology
- Cancer Biology
- Transcriptional Regulation
Background:
- Ewing sarcoma (EWS) is characterized by chromosomal translocations creating the EWS/FLI fusion gene.
- The EWS/FLI fusion protein acts as a transcription factor, driving oncogenesis.
- EWS and EWS/FLI are known to interact with transcriptional and splicing machinery.
Purpose of the Study:
- To investigate the interaction between U1C and the EWS/FLI fusion protein.
- To determine the functional consequences of the U1C-EWS/FLI interaction on transcriptional activity.
Main Methods:
- In vitro and in vivo interaction assays were performed.
- Co-expression studies were utilized to assess functional impact.
- Analysis of transcriptional activation mediated by EWS/FLI.
Main Results:
- U1C was found to interact with both EWS and the EWS/FLI fusion protein.
- U1C's interaction with EWS/FLI was shown to repress EWS/FLI-mediated transactivation.
- U1C's role in spliceosome formation was confirmed.
Conclusions:
- U1C, a splicing factor, can modulate transcriptional regulation.
- The interaction between U1C and EWS/FLI suggests a role in both transcriptional and post-transcriptional processes in Ewing sarcoma.
- These findings highlight a novel regulatory mechanism involving U1C in cancer biology.